Produits pharmaceutiques & dispositifs médicaux
Featured news
Other news
![](https://www.aim-mutual.org/wp-content/uploads/2020/04/14194682140_3df99e10f4_o.jpg)
EU Collaboration on Vaccination
The current outbreak of COVID-19, its crippling effects on European ec...
22.04.2020- Read more
![](https://www.aim-mutual.org/wp-content/uploads/2019/12/Fair-Pricing-design.png)
European patients need fair medicines prices
The press regularly announces the discovery of a new drug or the purch...
04.12.2019- Read more
![](https://www.aim-mutual.org/wp-content/uploads/2018/11/hip.jpg)
Medical Devices: Time to implement Regulations and increase Transparency
AIM, together with the European Association of Hospital Pharmacists (E...
26.02.2019- Read more
![](https://www.aim-mutual.org/wp-content/uploads/2018/02/scanner.jpg)
AIM director’s interview on HTA
AIM’s perspectives on Health Technology Assessments – An EU-wide a...
12.02.2018- Download
![](https://www.aim-mutual.org/wp-content/uploads/2018/01/tFA.png)
AIM publishes position on TFAs
AIM answered the open public consultation on the initiative to limit i...
22.01.2018- Read more
![](https://www.aim-mutual.org/wp-content/uploads/2017/04/medecine.jpg)
Press release: Dialogue between EMA and AIM
The AIM Working Group on Pharmaceuticals participated last week in Lon...
27.09.2017- Read more
![](https://www.aim-mutual.org/wp-content/uploads/2017/02/HTA.jpg)
AIM submits contribution to EC consultation on HTA
AIM fully supports the idea that, also after the finalization of EUnet...
13.02.2017- Download
![](https://www.aim-mutual.org/wp-content/uploads/2017/04/medecine.jpg)
Adaptive pathways: Why are we cautious?
In order to improve access to medicines, the European Medicines Agency...
30.06.2016- Download
![](https://www.aim-mutual.org/wp-content/uploads/2017/02/pathways.jpg)
AIM is cautious about adaptive pathways
AIM is cautious when ‘Adaptive Pathways’ are concerned. Please fin...
30.06.2016- Download